Sudarshan Chemical Industries Limited has informed regarding Disclosure of material issue. Appointment of Secretarial Auditor for a period of five years from FY2025-26 to 2029-30
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Chemical Industries reported audited FY25 results with standalone revenue of ₹2,533.9 crore (up ~18% YoY from ₹2,141.4 crore) and standalone PAT of ₹140.97 crore vs ₹335.12 crore in FY24 (which had a one-time land sale gain of ₹315.1 crore). Consolidated revenue surged ~32% to ₹3,345.6 crore, driven by the completion of the Heubach Group pigment business acquisition by subsidiary Sudarshan Europe B.V. on March 3, 2025 for €151.9 million. Consolidated results include an exceptional gain on bargain purchase of ₹1,243.85 crore from the Heubach deal. The Board recommended a final dividend of ₹4.50 per share (225% on face value of ₹2). Statutory auditor SRBC & Co LLP issued an unmodified opinion on standalone results but a modified opinion on consolidated results, with a Statement of Impact on Audit Qualifications filed. A Secretarial Auditor (M/s. J. B. Bhave & Co.) was appointed for 5 years (FY2025-26 to FY2029-30).
The Heubach acquisition has transformed Sudarshan into a much larger global pigments player, nearly doubling consolidated revenue and asset base, though leverage has risen sharply (consolidated borrowings up from ₹44 crore to ₹208 crore). The dividend payout signals confidence in cash generation. The modified audit opinion on consolidated results and exceptional bargain purchase gain warrant close attention from investors as underlying organic profitability and integration risks shape the true earnings picture.